American Capital Advisory’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57K Buy
141
+15
+12% +$694 ﹤0.01% 402
2026
Q1
$6.18K Sell
126
-3
-2% -$140 ﹤0.01% 378
2025
Q4
$5.62K Buy
129
+22
+21% +$1K ﹤0.01% 366
2025
Q3
$4.82K Sell
107
-9
-8% -$395 ﹤0.01% 359
2025
Q2
$5.04K Buy
116
+12
+12% +$534 ﹤0.01% 341
2025
Q1
$4.79K Buy
104
+6
+6% +$251 ﹤0.01% 341
2024
Q4
$3.69K Hold
98
﹤0.01% 374
2024
Q3
$3.97K Hold
98
﹤0.01% 362
2024
Q2
$3.52K Hold
98
﹤0.01% 325
2024
Q1
$4.11K Hold
98
﹤0.01% 318
2023
Q4
$3.52K Buy
+98
New +$3.77K ﹤0.01% 325

Other funds holding EXC

American Capital Advisory's EXC Position: Q2 2026 in Review

American Capital Advisory increased its Exelon (EXC) stake by 12% in Q2 2026, buying an estimated $694 and bringing the position to 141 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

American Capital Advisory first reported a position in EXC in Q4 2023 and has held it in 11 quarters since. 1,290 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • American Capital Advisory held 141 shares of Exelon worth $6.57K as of Q2 2026.
  • American Capital Advisory bought 15 Exelon shares in Q2 2026, an estimated $694.
  • Exelon made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #402 holding.
  • American Capital Advisory first reported a position in Exelon in Q4 2023 and has held it in 11 quarters since.
  • 1,290 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.